Ireland
--:--IST
Latest
Clinical Trials in Turkey / NCT07431736
Active, not recruiting Not applicable

Laser Therapy for Dentin Hypersensitivity

NCT07431736 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-11-11
Last updated
2026-02-25

Condition(s) studied

Dentin Hypersensitivity

Investigational drug(s) / intervention(s)

Er,Cr;YSGG Laser, Waterlase, Biolase Technology Inc., Irvine, CA, ABDRemin Pro (VOCO, Cuxhaven, Germany)

Er,Cr;YSGG Laser, Waterlase, Biolase Technology Inc., Irvine, CA, ABD: Er,Cr;YSGG Laser

Remin Pro (VOCO, Cuxhaven, Germany): a hydroxyapatite-containing remineralizing agent

Study summary

A 12-Month Comparative Clinical Evaluation of the Efficacy of Er,Cr:YSGG Laser Irradiation, Remin Pro Application, and Their Combined Therapy in the Treatment of Dentin Hypersensitivity.

Eligibility

Sex
ALL
Min age
18 Years
Max age
70 Years
Healthy volunteers
Accepted
Inclusion Criteria: Being between 18 and 70 years of age; voluntarily agreeing to participate in the study and providing written informed consent; not receiving any analgesic therapy; not having any systemic disease that could interfere with the treatment outcomes; not being pregnant or breastfeeding; presenting with at least four teeth exhibiting a Visual Analog Scale (VAS) score of 4 or higher; not exhibiting cervical abrasion-related substance loss of sufficient depth to require restorative treatment; absence of extensive or defective restorations or caries in the sensitive teeth; absence of pulpitis; and absence of hypersensitivity associated with recent periodontal procedures. Exclusion Criteria: Being younger than 18 years or older than 70 years of age; unwillingness to participate in the study voluntarily; receiving any analgesic therapy; presence of a systemic disease that could interfere with the treatment outcomes; being pregnant or breastfeeding; presence of substance loss of sufficient depth to require restorative treatment or the presence of enamel fracture; presence of extensive or defective restorations or caries in the sensitive teeth; presence of pulpitis; having received periodontal treatment within the three months prior to the initiation of the study and exhibiting persistent hypersensitivity related to that treatment; and developing a need for periodontal treatment (e.g., scaling or root planing) during the study period.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hacettepe University Ankara Turkey (Türkiye)

More Hacettepe University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07431736 on ClinicalTrials.gov ↗ ← All trials in Turkey